Prenetics Global Limited Buyback
OLI recorded this information on 11/30/2022
Company:
Prenetics Global Limited
Buyback:
PRE buyback
$Amount Authorized:
$20,000,000
Buyback Details:
Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a global leader in genomic and diagnostic testing, today announced that its board of directors has authorized a share repurchase program, and that it has been included as a constituent stock in the MSCI Global Micro Cap Index (Hong Kong), with such inclusion to become effective after the U.S. market close today. The Company's board of directors has authorized a share repurchase program under which the Company may repurchase its class A ordinary shares with an aggregate value of up to US$20 million during a 24-month period (the "Repurchase Program").
Prenetics Global is a holding company. Through its subsidiary, Prenetics Holding Company Limited, Co. is a diagnostics and genetics testing products and services provider. Co.'s pipeline products and services include: ColoClear, which is a non-invasive fecal immunochemical test and multi-target stool-based DNA testing colorectal cancer screening test; Circle SnapShot, which is an off-the-shelf at-home blood test where individuals can get digital access to their own health information; and Circle One, F1x and Fem, which develop to provide its customers personalized nutrition, hair loss and sexual health products tailored to each of its customer's genetic variation and biology.
Preferreds: PRE.PRC, PRE.PRD, PRE.PRE, PRE.PRF, PRE.PRG, PRE.PRH, PRE.PRI, PRE.PRJ
Open the PRE Page at The Online Investor »
|
||||||||||||
Open the PRE Page at The Online Investor (in a new window) »
 Free PRE Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
|
Strong Buy (4.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
